22 May 2013
Keywords: roche, glycart, enter, into, antibody, collaboration, swiss
Article | 27 September 2004
Swiss firms Roche and GLYCART biotechnology say that they have entered into an agreement to discover next-generation antibodies using GlycoMAb
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
27 September 2004
21 May 2013
© 2013 thepharmaletter.com